Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(60%)

Phase Distribution

Ph phase_4
1
20%
Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Terminated(3)
Other(1)

Detailed Status

Terminated3
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
25.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

completed120%
terminated360%
unknown120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5